Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

VENUS REMEDIES vs ALEMBIC PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    VENUS REMEDIES ALEMBIC PHARMA VENUS REMEDIES/
ALEMBIC PHARMA
 
P/E (TTM) x 15.0 32.2 46.6% View Chart
P/BV x 0.9 4.4 21.5% View Chart
Dividend Yield % 0.0 0.8 -  

Financials

 VENUS REMEDIES   ALEMBIC PHARMA
EQUITY SHARE DATA
    VENUS REMEDIES
Mar-23
ALEMBIC PHARMA
Mar-23
VENUS REMEDIES/
ALEMBIC PHARMA
5-Yr Chart
Click to enlarge
High Rs379792 47.8%   
Low Rs145463 31.3%   
Sales per share (Unadj.) Rs415.5287.6 144.5%  
Earnings per share (Unadj.) Rs19.917.4 114.2%  
Cash flow per share (Unadj.) Rs44.031.4 140.2%  
Dividends per share (Unadj.) Rs08.00 0.0%  
Avg Dividend yield %01.3 0.0%  
Book value per share (Unadj.) Rs344.3222.3 154.8%  
Shares outstanding (eoy) m13.37196.56 6.8%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x0.62.2 28.9%   
Avg P/E ratio x13.236.1 36.5%  
P/CF ratio (eoy) x5.920.0 29.8%  
Price / Book Value ratio x0.82.8 26.9%  
Dividend payout %046.0 0.0%   
Avg Mkt Cap Rs m3,501123,402 2.8%   
No. of employees `000NANA-   
Total wages/salary Rs m57011,691 4.9%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m5,55556,526 9.8%  
Other income Rs m10330 339.5%   
Total revenues Rs m5,65856,557 10.0%   
Gross profit Rs m6026,772 8.9%  
Depreciation Rs m3232,754 11.7%   
Interest Rs m3502 0.6%   
Profit before tax Rs m3793,546 10.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m114126 90.1%   
Profit after tax Rs m2663,420 7.8%  
Gross profit margin %10.812.0 90.5%  
Effective tax rate %30.03.6 842.5%   
Net profit margin %4.86.1 79.0%  
BALANCE SHEET DATA
Current assets Rs m3,23029,139 11.1%   
Current liabilities Rs m82616,408 5.0%   
Net working cap to sales %43.322.5 192.1%  
Current ratio x3.91.8 220.2%  
Inventory Days Days3710 381.0%  
Debtors Days Days5047 7,454.6%  
Net fixed assets Rs m2,78131,498 8.8%   
Share capital Rs m134393 34.0%   
"Free" reserves Rs m4,47043,312 10.3%   
Net worth Rs m4,60343,705 10.5%   
Long term debt Rs m3870-   
Total assets Rs m6,01160,637 9.9%  
Interest coverage x130.08.1 1,611.5%   
Debt to equity ratio x0.10-  
Sales to assets ratio x0.90.9 99.1%   
Return on assets %4.56.5 69.1%  
Return on equity %5.87.8 73.8%  
Return on capital %7.79.3 82.7%  
Exports to sales %046.4 0.0%   
Imports to sales %012.1 0.0%   
Exports (fob) Rs mNA26,210 0.0%   
Imports (cif) Rs mNA6,846 0.0%   
Fx inflow Rs m026,210 0.0%   
Fx outflow Rs m06,846 0.0%   
Net fx Rs m019,364 0.0%   
CASH FLOW
From Operations Rs m3667,240 5.1%  
From Investments Rs m-508-4,476 11.4%  
From Financial Activity Rs m-6-2,620 0.2%  
Net Cashflow Rs m-220144 -153.2%  

Share Holding

Indian Promoters % 41.8 69.1 60.4%  
Foreign collaborators % 0.0 0.5 -  
Indian inst/Mut Fund % 1.6 19.0 8.4%  
FIIs % 1.6 4.5 35.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 58.2 30.4 191.6%  
Shareholders   19,560 85,212 23.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare VENUS REMEDIES With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on VENUS REMEDIES vs ALEMBIC PHARMA

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

VENUS REMEDIES vs ALEMBIC PHARMA Share Price Performance

Period VENUS REMEDIES ALEMBIC PHARMA S&P BSE HEALTHCARE
1-Day 7.05% -0.15% 1.18%
1-Month -4.10% -4.30% -0.75%
1-Year 103.11% 105.43% 61.82%
3-Year CAGR 4.62% 0.89% 18.16%
5-Year CAGR 58.05% 13.56% 19.79%

* Compound Annual Growth Rate

Here are more details on the VENUS REMEDIES share price and the ALEMBIC PHARMA share price.

Moving on to shareholding structures...

The promoters of VENUS REMEDIES hold a 41.8% stake in the company. In case of ALEMBIC PHARMA the stake stands at 69.6%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of VENUS REMEDIES and the shareholding pattern of ALEMBIC PHARMA.

Finally, a word on dividends...

In the most recent financial year, VENUS REMEDIES paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of 0.0%.

ALEMBIC PHARMA paid Rs 8.0, and its dividend payout ratio stood at 46.0%.

You may visit here to review the dividend history of VENUS REMEDIES, and the dividend history of ALEMBIC PHARMA.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.